Binta M. Robinson

Array ( [id] => 892598 [patent_doc_number] => 07345177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Vapor phase catalytic chlorination of β-picoline' [patent_app_type] => utility [patent_app_number] => 11/114831 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3558 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345177.pdf [firstpage_image] =>[orig_patent_app_number] => 11114831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926598 [patent_doc_number] => 20050239855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation' [patent_app_type] => utility [patent_app_number] => 11/112423 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63181 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239855.pdf [firstpage_image] =>[orig_patent_app_number] => 11112423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239641 [patent_doc_number] => 07592358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds' [patent_app_type] => utility [patent_app_number] => 11/104889 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40487 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592358.pdf [firstpage_image] =>[orig_patent_app_number] => 11104889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801559 [patent_doc_number] => 20060035940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => '(S)-Amlodipine malate' [patent_app_type] => utility [patent_app_number] => 11/082253 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 25905 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035940.pdf [firstpage_image] =>[orig_patent_app_number] => 11082253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404824 [patent_doc_number] => 07288657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Biphenyl compounds useful as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/077433 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26955 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288657.pdf [firstpage_image] =>[orig_patent_app_number] => 11077433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570310 [patent_doc_number] => 20090253688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Semicarbazide derivatives as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/590664 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49038 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253688.pdf [firstpage_image] =>[orig_patent_app_number] => 10590664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040268 [patent_doc_number] => 20050159314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Process for the preparation of cyclic diketones' [patent_app_type] => utility [patent_app_number] => 11/056406 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12181 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159314.pdf [firstpage_image] =>[orig_patent_app_number] => 11056406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7006042 [patent_doc_number] => 20050171355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Pyridine derivative production method' [patent_app_type] => utility [patent_app_number] => 11/046743 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10149 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171355.pdf [firstpage_image] =>[orig_patent_app_number] => 11046743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6942513 [patent_doc_number] => 20050194561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Anionic-sweetener-based ionic liquids and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/046561 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33357 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20050194561.pdf [firstpage_image] =>[orig_patent_app_number] => 11046561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200473 [patent_doc_number] => 20050165015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/040995 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14602 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165015.pdf [firstpage_image] =>[orig_patent_app_number] => 11040995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200473 [patent_doc_number] => 20050165015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/040995 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14602 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165015.pdf [firstpage_image] =>[orig_patent_app_number] => 11040995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098573 [patent_doc_number] => 20050131032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '(Oxime)carbamoyl fatty acid amide hydrolase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/039516 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21530 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131032.pdf [firstpage_image] =>[orig_patent_app_number] => 11039516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 300025 [patent_doc_number] => 07538227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Process for stabilizing 4-halopyridines' [patent_app_type] => utility [patent_app_number] => 11/035142 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2031 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538227.pdf [firstpage_image] =>[orig_patent_app_number] => 11035142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250902 [patent_doc_number] => 07582658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Bicyclic compound' [patent_app_type] => utility [patent_app_number] => 11/019632 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76614 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582658.pdf [firstpage_image] =>[orig_patent_app_number] => 11019632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035423 [patent_doc_number] => 20070099962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => '5,6-Dihydropyrin-2-one compounds useful as inhibitors of thrombin' [patent_app_type] => utility [patent_app_number] => 10/596506 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34033 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099962.pdf [firstpage_image] =>[orig_patent_app_number] => 10596506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903494 [patent_doc_number] => 07335687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => '2,3-Oxidosqualene-lanosterol cyclase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/014374 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61319 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335687.pdf [firstpage_image] =>[orig_patent_app_number] => 11014374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586059 [patent_doc_number] => 07442714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Amlodipine gentisate and a method of its preparation' [patent_app_type] => utility [patent_app_number] => 10/583438 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3616 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442714.pdf [firstpage_image] =>[orig_patent_app_number] => 10583438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7056505 [patent_doc_number] => 20050277680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Compounds for treatment of cell proliferative diseases' [patent_app_type] => utility [patent_app_number] => 11/010834 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12961 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277680.pdf [firstpage_image] =>[orig_patent_app_number] => 11010834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005847 [patent_doc_number] => 20050171160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Doxepin analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/008891 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 48272 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171160.pdf [firstpage_image] =>[orig_patent_app_number] => 11008891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510792 [patent_doc_number] => 07196100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/581164 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12173 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196100.pdf [firstpage_image] =>[orig_patent_app_number] => 10581164 [rel_patent_id] =>[rel_patent_doc_number] =>)